Most treatment plans for Dezawa Muse cell therapy in the United States fall in the range of $8,000 to $25,000, depending on the condition being treated, the number of sessions required, cell dosage, and administration method. Insurance does not cover this therapy. Financing options are available. Regener8MD discusses specific pricing with each patient during a complimentary consultation - there is no one-size-fits-all protocol, which means there is no one-size-fits-all price.
The cost of Dezawa Muse cell therapy: an overview
Cost is one of the most practical questions patients ask, and it deserves a direct answer. Dezawa Muse cell therapy is a significant financial investment. That is true across the regenerative medicine landscape - specialized cell therapies in the United States typically range from $5,000 for simpler single-joint protocols to $35,000 or more for complex systemic conditions.
Within that spectrum, Dezawa Muse cell therapy generally falls in the $8,000 to $25,000 range for a complete treatment plan. The wide range reflects meaningful differences in what each patient actually needs - not arbitrary pricing variation. A single intravenous infusion for a focused application will cost considerably less than a multi-session protocol designed to address a systemic or progressive condition.
At Regener8MD, Dr. Capasso reviews your health history and goals during an initial consultation before discussing any specific investment. There is no standard package price because there is no standard patient.
What determines the cost of a Dezawa Muse cell therapy protocol
Several variables interact to set the total investment for any given treatment plan. Understanding them helps you evaluate what you are comparing when you research options.
The condition being treated and its severity
A focused orthopedic application - one joint, one defined area of damage - typically requires a lower dose and fewer sessions than a cardiovascular or neurological condition that involves multiple organ systems. More advanced or longer-standing conditions generally require more robust protocols to address the degree of tissue involvement.
Cell dosage
Authentic Dezawa Muse cells from a licensed, SSEA-3-verified source carry significant production costs. The raw material cost for premium cell products from certified laboratories runs in the hundreds to over a thousand dollars per dose before clinic overhead is factored in. Higher doses, required for more demanding conditions, increase the material cost directly. This is one reason to be skeptical of unusually low price quotes for any cell therapy - verified, quality-controlled Muse cell products cannot be produced or delivered for a few hundred dollars.
Number of sessions
Some patients achieve meaningful results from a single treatment. Others benefit from a series of infusions spaced over months. The protocol Dr. Capasso recommends is based on your specific clinical picture, not a default schedule. Multi-session protocols naturally carry higher total costs than a single session.
Administration method
Intravenous infusion is the method used in published clinical trials and is generally the most straightforward approach. Targeted delivery routes - intra-articular injection directly into a joint, intrathecal delivery for spinal conditions, or other site-specific administration - can increase procedural complexity and cost. The goal is always to match the delivery method to the clinical need.
Monitoring and follow-up
A responsible regenerative medicine protocol includes structured follow-up to assess response. The extent of post-treatment monitoring included in a plan affects the total investment. At Regener8MD, follow-up is built into the treatment relationship, not treated as an add-on.
- Focused single-area application (lower end): $8,000 to $12,000
- Standard protocol with follow-up: $12,000 to $18,000
- Multi-session or systemic protocol (upper end): $18,000 to $25,000
- Regener8MD pricing: Determined during consultation based on individual protocol
Does insurance cover Dezawa Muse cell therapy?
No. Standard health insurance plans and Medicare do not cover Dezawa Muse cell therapy in the United States. The primary reason is regulatory classification: because the therapy has not received approval from the U.S. Food and Drug Administration, insurers categorize it as elective or experimental. therapy, many biologic injections, and numerous advanced cell therapies face the same coverage gap.
This means the full investment comes out of pocket. Regener8MD provides transparent, specific pricing at consultation so you can make a fully informed decision about whether to proceed. There are no surprises after you commit.
For a broader discussion of the regulatory context around Dezawa Muse cell therapy, see Are Dezawa Muse Cells FDA Approved? What Patients Need to Know.
Can I use an HSA or FSA for Muse cell therapy?
Possibly, but it is not guaranteed. Health savings accounts (HSAs) and flexible spending accounts (FSAs) are governed by IRS rules that allow reimbursement for expenses that diagnose, treat, or prevent a specific medical condition. The critical phrase is "specific medical condition" - general wellness spending does not qualify.
Because Dezawa Muse cell therapy is not FDA-approved, there is no categorical ruling that makes it automatically HSA or FSA eligible. Some patients have successfully applied these funds to regenerative medicine treatments with documentation of medical necessity. The typical path involves:
- Obtaining a Letter of Medical Necessity from your physician that connects the treatment to a specific diagnosed condition
- Confirming with your HSA or FSA administrator whether they will accept the expense given that documentation
- Consulting a tax professional if you have any uncertainty about IRS qualification in your specific situation
Neither Dr. Capasso nor Regener8MD can guarantee HSA or FSA eligibility for your situation. What we can tell you is that the question is worth asking before your consultation - some patients are able to offset a meaningful portion of the cost through these accounts.
What financing options are available?
Regener8MD works with third-party healthcare financing to help make treatment accessible for patients whose goals align with what this therapy offers but who prefer to spread the investment over time.
CareCredit
CareCredit is a healthcare credit card accepted at over 250,000 enrolled providers nationally. It offers promotional financing periods - often interest-free for 12 to 24 months - that allow you to pay for the full treatment without interest if the balance is cleared within the promotional window. Standard interest rates apply after that period.
PatientFi
PatientFi offers installment plans up to 60 months with prequalification that does not affect your credit score. It is designed specifically for healthcare expenses that fall outside insurance coverage, with credit limits structured to accommodate higher-cost procedures.
GreenSky Patient Solutions
GreenSky offers both installment loans and revolving credit options, with loan amounts up to $65,000 depending on qualification. This option is relevant for patients with more comprehensive protocols that approach the higher end of the cost range.
Availability and terms depend on your individual credit profile. Regener8MD's team will walk you through financing options at your consultation so you have a complete picture before making any decision.
How does the cost compare to joint replacement surgery?
Joint replacement is the most common surgical alternative for patients dealing with advanced joint deterioration. Understanding the full cost comparison is useful context for any patient weighing options.
| Option | Typical U.S. Cost Range | Notes |
|---|---|---|
| Dezawa Muse cell therapy | $8,000 – $25,000 | Out of pocket; no surgery or general anesthesia required |
| Total knee replacement | $29,000 – $50,000 | Includes hospital, surgeon, anesthesia, and rehabilitation |
| Total hip replacement | $20,000 – $40,000 | Similar cost structure to knee replacement |
Beyond the dollar comparison, joint replacement is a permanent structural change. Bone and cartilage are removed and replaced with metal and polymer components. Recovery typically spans months and may involve temporary mobility limitations, physical therapy, and surgical risk. Implants have a finite lifespan and may eventually require revision surgery.
Dezawa Muse cell therapy does not involve surgery, does not permanently alter joint structure, and carries a different risk profile. In published clinical trial data, no serious adverse events have been reported and no immunosuppressive medication is required. Whether it is the right choice for any given patient depends on the specifics of their condition - but the cost comparison alone suggests it is worth understanding before committing to surgery. Read about the conditions Dezawa Muse cells are being studied for to get a clearer picture of where this therapy may be relevant.
How does the cost compare to long-term pain management?
For many patients considering regenerative medicine, the realistic alternative is not a single surgery - it is ongoing chronic pain management. That cost structure looks very different over time.
A standard chronic pain management program can include prescription medications, corticosteroid or hyaluronic acid injections (typically $300 to $1,000 per injection, repeated every few months), regular physical therapy sessions ($150 to $300 each), and periodic imaging. A conservative estimate for a patient with moderate joint pain runs $500 to $2,000 or more per month.
Over five years, that is $30,000 to $120,000 - with no change in the underlying tissue and the real possibility that the condition continues to progress. The financial comparison matters, but the more meaningful distinction is that chronic pain management addresses symptoms rather than the structural damage causing them.
Dezawa Muse cell therapy is an investment in a different approach: targeting the tissue itself with the goal of actual regeneration. Whether that goal is achievable in a given patient's situation is something Dr. Capasso addresses directly during consultation, including an candid assessment of what outcomes are realistic for your specific condition and health profile.
Are there package or membership pricing options?
Regener8MD does not offer standardized treatment packages because standard packages are not how regenerative medicine works responsibly. A patient with early-stage joint deterioration needs a very different protocol than a patient addressing cardiovascular damage or a neurological condition. Grouping them into a common price tier would mean over-treating some patients and under-treating others.
What Regener8MD does offer is a complimentary 45-minute consultation with Dr. Capasso. In that session, he reviews your complete health history, explains what a protocol for your situation would actually involve, and gives you specific pricing so you can make a fully informed decision. Some protocols include follow-up sessions and monitoring as part of the total plan - those costs are disclosed upfront, not added later.
A note on price variation across providers
If you research Dezawa Muse cell therapy pricing across providers, you will encounter a significant range - from providers advertising very low entry prices to others at the upper end of the spectrum. That variation is worth understanding before you draw conclusions from price alone.
Authentic Dezawa Muse cells require SSEA-3 verification and are produced under patented, quality-controlled manufacturing processes by licensed sources. That production cost is real and is reflected in the price of legitimate treatment. Providers advertising unusually low prices for "Muse cells" or similar therapies may be offering products that are not SSEA-3 verified, not from a licensed manufacturing source, or not Dezawa Muse cells at all.
Regener8MD uses only authentic Dezawa Muse cells from MuseCell Innovations, the licensed source, with certificate of analysis and SSEA-3 verification on every batch. For patients evaluating cost, the relevant question is not just what the total price is - it is what you are actually receiving for that price. Read how to evaluate Dezawa Muse cell providers for a more complete guide to what separates authentic programs from imitators.
Data sources for cost ranges cited in this article
- Regenerative medicine cost ranges: QC Kinetix patient guide (2025); Waters Edge Medical Clinic regenerative injection cost guide (2026); PubMed: "Variability in Patient-Incurred Costs and Protocols of Regenerative Medicine Procedures for Musculoskeletal Conditions in the United States" (PMC9837410)
- Stem cell therapy cost in the U.S.: BioInformant cost overview (2026); DVC Stem cost update (2026); Stem Aid Institute patient guide (2025)
- Joint replacement surgery costs: GoodRx hip replacement cost data; HealthLine knee replacement cost review; Journal of Orthopaedic Surgery and Research (average $29,300 for uncomplicated total knee replacement)
- Healthcare financing options: Stemedix financing overview; Innovations Stem Cell Center financing; CareCredit provider network data
- HSA/FSA eligibility rules: IRS Publication 502 (Medical and Dental Expenses); IRS FAQ on nutrition, wellness, and general health expenses; HSABank qualified medical expense list
- Regener8MD cost range ($8,000 to $25,000): Source - Regener8MD internal treatment planning documentation (Email 4, Concern #6)
Frequently asked questions
How much does Dezawa Muse cell therapy cost?
Most treatment plans in the United States fall in the range of $8,000 to $25,000 depending on the condition, number of sessions, cell dosage, and administration method. Regener8MD's specific pricing for your protocol is discussed during a complimentary consultation with Dr. Capasso.
What determines the cost of Muse cell therapy?
The main cost drivers are: the condition and its severity, the number of treatment sessions, the cell dose required, the administration method (intravenous versus targeted injection), and the monitoring included in the plan. More complex conditions with greater tissue involvement require higher doses and more sessions.
Is Muse cell therapy covered by insurance?
No. Standard health insurance and Medicare do not cover Dezawa Muse cell therapy because it has not received FDA approval. The full cost is paid out of pocket. Financing options are available to help spread the investment over time.
Can I use my HSA or FSA for Muse cell therapy?
It depends on your specific circumstances. Some patients have used HSA or FSA funds with a Letter of Medical Necessity connecting the treatment to a diagnosed condition. Because the therapy is not FDA-approved, eligibility is not guaranteed. Confirm with your account administrator and consult a tax professional before applying these funds.
What financing options are available?
Regener8MD works with third-party healthcare financing including CareCredit, PatientFi, and GreenSky. These allow patients to spread the investment over 12 to 60 months depending on the lender and your credit profile. Promotional interest-free periods may be available. Details are discussed at consultation.
How does Muse cell therapy cost compare to knee or hip replacement surgery?
Total knee replacement in the U.S. averages $29,000 to $50,000. Total hip replacement runs $20,000 to $40,000. Dezawa Muse cell therapy, at $8,000 to $25,000, typically falls below the cost of surgery and does not involve the recovery period, surgical risk, or permanent structural alteration that joint replacement requires.
How does the cost compare to ongoing pain management?
Chronic pain management through medications, injections, and physical therapy typically costs $500 to $2,000 or more per month with no end date and no structural improvement to the underlying tissue. Over five years, cumulative costs often exceed the total investment for a Dezawa Muse cell protocol. The distinction goes beyond dollars: chronic management addresses symptoms; regenerative therapy targets the tissue itself.
Why is there such a wide price range across providers advertising Muse cells?
Significant price variation in this space is a signal worth investigating. Authentic Dezawa Muse cells require SSEA-3 verification and licensed manufacturing - those costs are real and reflected in legitimate pricing. Unusually low prices for claimed "Muse cell therapy" may indicate unverified products, unlicensed sources, or a different therapy altogether. Ask any provider for their SSEA-3 verification and their licensing relationship with MuseCell Innovations before comparing price.
Get specific pricing for your situation
Dr. Capasso offers a complimentary 45-minute consultation to review your health history, explain what a protocol for your situation would involve, and give you transparent pricing - so you can make a fully informed decision.
Book a Consultation